跳至主要内容
临床试验/CTRI/2026/03/105889
CTRI/2026/03/105889尚未招募2 期

A PROSPECTIVE, OPEN LABELLED, SINGLE ARM, NON-RANDOMIZED, SINGLE CENTRIC, PHASE II, CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF VEPPAMPISIN CHOORANAM IN THE MANAGEMENT OF MADHUMEGAM (TYPE II DIABETES MELLITUS)

Government Siddha Medical College1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年3月25日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

This study is a prospective open labelled, single arm, non-randomized, single centric, phase II clinical trial to determine the effectiveness of VEPPAMPISIN CHOORANAM in the management of MADHUMEGAM (TYPE II DIABETES MELLITUS). The trial drug will be administered at the dose of 1 gram twice a day for 90 days in 40 patients.  The primary outcome will be the evaluation of therapeutic efficacy of the trial drug VEPPAMPISIN CHOORANAM.The secondary outcome will be the evaluation of siddha diagnostic parameters, assessment of  biochemical and phytochemical parameters of the trial drug will be performed

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 59.00 Year(s)(—)
性别
All

入选标准

  • If patient is having anyone among the three(WHO Criteria 2019) FBS-Above 126mg/dl and below 250mg/dl or PPBS-Above 200mg/dl and below 350mg/dl or HbA1c-6.5% to 10% Patients with symptoms of polyuria, polydipsia, polyphagia and nocturia.

排除标准

  • Type 1 Diabetes Mellitus Gestational DM Diabetes Insipidus Pregnancy Lactating mother Chronic kidney disease Chronic liver disease Ischaemic heart disease.

研究者

发起方
Government Siddha Medical College
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

DR M SOUNDHARYA

Government Siddha Medical College and Hospital, Palayamkottai.

研究点 (1)

Loading locations...

相似试验